Parkinson's disease (PD) is a neurodegenerative disease that occurs mostly in middle-aged and elderly people. The main pathological changes are degeneration and necrosis of dopaminergic neurons in the substantia nigra of the midbrain, which results in damage of the substantia nigra striatal pathway and decrease of dopamine content in the putamen and caudate nucleus. The main clinical symptoms of PD patients were motor retardation, quiescent tremor, postural gait disorder and myotonia. It is known that the process of degenerative death of PD dopaminergic neurons is related to genetic factors, age, environmental factors and oxidative stress.
Lipoic acid (LA) is a vitamin-like coenzyme, which mainly exists in mitochondria. LA is both lipid-soluble and water-soluble, and can reach any part of cells in a short time. LA can inhibit the production of free radicals, antioxidant and anti-inflammatory effects. The above characteristics are conducive to improving the clinical symptoms of PD patients.
It can improve the symptoms of PD.
It can effectively alleviate the decrease of TH levels in substantia nigra and striatum, inhibit inflammation and reduce oxidative stress.
It has both fat solubility and water solubility, can cross the blood-brain barrier and diffuse rapidly in the brain.
It has the functions of anti-oxidation, anti-inflammation, increasing glutathione formation, and inhibiting free radical formation by scavenging metal elements.
It can effectively inhibit the excessive activation of astrocytes and microglia, thereby reducing the release of inflammatory factors and protecting dopaminergic neurons.
Shaanxi, China (Mainland)
Antibiotic and Antimicrobial Agents
20 Ton/Tons per Month
Packaging & Delivery
Alpha Lipoic Acid Powder Bulk & Private Label Packaging for your options:
* 1~5 kg in a Al-Foil Bag w/ Zip lock Bag inside
* 5~20 kg in a Paper Carton
* 25kg in a Paper Drum w/ Double Plastic Bags inside
3 days after payment